Circular RNA cFAM210A, Degradable by HBx, Inhibits HCC Tumorigenesis by Suppressing YBX1 Transactivation

Investigators found that cFAM210A could be silenced by hepatitis B protein x (HBx). cFAM210A expression was downregulated and negatively correlated with tumorigenesis in patients with hepatitis B virus-related HCC.